Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy
- 1 January 1996
- journal article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 23 (8) , 953-957
- https://doi.org/10.1007/bf01084370
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Estimation of Radiation Absorbed Doses to the Red Marrow in RadioimmunotherapyClinical Nuclear Medicine, 1995
- Body and blood clearance and marrow radiation dose of 131I-Lym-1 in patients with B-cell malignanciesNuclear Medicine Communications, 1993
- Isoeffect relationships for fractionated biologically targeted radiotherapyRadiotherapy and Oncology, 1990
- Radiobiological aspects of low dose rates in radioimmunotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1990
- The linear-quadratic formula and progress in fractionated radiotherapyThe British Journal of Radiology, 1989
- Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic modelThe British Journal of Radiology, 1989
- Treatment of B cell malignancies with 131I Lym-1 monoclonal antibodies.1988
- Treatment of B cell malignancies with131I LYM-1 monoclonal antibodiesInternational Journal of Cancer, 1988
- 2 NEW MONOCLONAL-ANTIBODIES, LYM-1 AND LYM-2, REACTIVE WITH HUMAN B-LYMPHOCYTES AND DERIVED TUMORS, WITH IMMUNODIAGNOSTIC AND IMMUNOTHERAPEUTIC POTENTIAL1987
- The cellular basis of long-term marrow injury after irradiationRadiotherapy and Oncology, 1985